Dr. Ali Alfakeeh


Chairman and consultant medical Oncology
King Fahad medical city, comprehensive cancer center, Riyadh



Saturday 4-5-2024 Day 2

Biliary tract cancer

  • Immunetherapy in advanced BTC: Yes/No
  • Which agent?
  • Patient selection/tumour location?
  • Role of maintenance therapy?
  • Role of liquid biopsy/biomarker assessment

Moderator: Dr. Mohammed Algarni



Saturday 4-5-2024 Day 2

Perioperative therapy in Gastric cancer

  • Role of laparoscopy assessment before perioperative therapy?
  • What to do in patients with poor response to neoadjuvant therapy?
  • Role of biomarkers e.g MSI in decision-making before perioperative therapy?
  • Patients with limited peritoneal metastasis: Role of HIPEC?
  • Role of immunetherapy with perioperative therapy non-metastatic gastric cancer?

Moderator:  Dr. Fahad Ibnshamsah